FDA Schedules Meeting With Cellceutix on New Psoriasis Drug - MarketWatch (press release)

FDA Schedules assemblage With Cellceutix on brand-new Psoriasis Drug MarketWatch (press release) The FDA has confirmed mid-June 2012 for a pre-IND meeting focused on Prurisol(TM) to speech act guidance on the Cellceutix initiatives to advance development of this new drug for treating psoriasis . In March 2012, Cellceutix submitted documentation in ... Cellceutix touts potential disease of the skin treatment Boston Herald FDA schedules meeting with Cellceutix on psoriasis drug Boston.com all 8 news articles » Link To Article